Pfizer Inc’s recently made public that its Former Officer Dolsten Mikael acquired Company’s shares for reported $1.38 million on May 23 ’25. In the deal valued at $23.09 per share,59,781 shares were bought.
Then, Dolsten Mikael bought 55,000 shares, generating $1,312,736 in total proceeds.
Before that, DAMICO JENNIFER B. sold 2,500 shares. Pfizer Inc shares valued at $64,825 were divested by the SVP & Controller at a price of $25.93 per share. As a result of the transaction, DAMICO JENNIFER B. now holds 11,850 shares, worth roughly $0.28 million.
Cantor Fitzgerald initiated its Pfizer Inc [PFE] rating to a Neutral in a research note published on April 22, 2025; the price target was $24. Wolfe Research began covering PFE with “an Underperform” recommendation on November 15, 2024.
Price Performance Review of PFE
On Friday, Pfizer Inc [NYSE:PFE] saw its stock jump 0.99% to $23.35. Over the last five days, the stock has lost -0.60%. Pfizer Inc shares have fallen nearly -11.99% since the year began. Nevertheless, the stocks have fallen -20.82% over the past one year. While a 52-week high of $31.54 was reached on 01/07/25, a 52-week low of $20.92 was recorded on 04/09/25. SMA at 50 days reached $23.16, while 200 days put it at $26.16.
Levels Of Support And Resistance For PFE Stock
The 24-hour chart illustrates a support level at 23.20, which if violated will result in even more drops to 23.06. On the upside, there is a resistance level at 23.54. A further resistance level may holdings at 23.73. The Relative Strength Index (RSI) on the 14-day chart is 51.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.02%. Stochastics %K at 67.11% indicates the stock is a holding.
The most recent change occurred on October 17, 2024 when Bernstein began covering the stock and recommended ‘”a Mkt perform”‘ rating along with a $32 price target.
